XML 32 R19.htm IDEA: XBRL DOCUMENT v3.3.0.814
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Dec. 31, 2014
Nov. 30, 2010
Earnings Per Common Share            
Weighted average common stock equivalents from assumed exercise of stock options (in shares)   26,750   26,750    
Outstanding options excluded from computation of earnings per share as effect would be antidilutive (in shares) 123,750 169,250 125,500 178,139    
Maximum | Total Sales            
Revenue Recognition            
Percentage of sales (as a percent)     5.00%      
Stock Options            
Options            
Balance at the beginning of the period(in shares)     181,000      
Granted (in shares) 0 0 0 0    
Exercised (in shares)   0 (3,333) 0    
Cancelled (in shares) 0   (37,917)      
Balance at the end of the period (in shares) 139,750   139,750   181,000  
Exercisable at the end of the period (in shares) 134,917   134,917      
Weighted-Average Exercise Price Per Share            
Outstanding at the beginning of the period (in dollars per share)     $ 6.36      
Exercised (in dollars per share)     3.20      
Cancelled (in dollars per share)     5.52      
Outstanding at the end of the period (in dollars per share) $ 6.66   6.66   $ 6.36  
Exercisable at the end of the period (in dollars per share) $ 6.78   $ 6.78      
Weighted-Average Remaining Contractual Term            
Outstanding at the end of the period     2 years 2 months 27 days      
Exercisable at the end of the period     2 years 22 days      
Aggregate Intrinsic Value            
Outstanding at the end of the period $ 16,800   $ 16,800      
Exercisable at the end of the period 11,725   11,725      
Additional disclosures            
Intrinsic value of options exercised 8,166   8,166      
Cash received from options exercised 10,666   10,666      
Compensation expense 1,989 $ 7,482 1,320 $ 22,445    
Unrecognized compensation related to unvested awards $ 3,000   $ 3,000      
Weighted-average period over which unrecognized compensation costs expected to be recognized     4 months 13 days      
Equity Appreciation Rights Plan            
Awards exercised (in shares)   0 3,333 0    
Granted (in shares) 0 0 0 0    
2010 Plan | Equity Appreciation Rights Plan            
Additional disclosures            
Compensation expense $ (37,000) $ 38,000 $ (95,000) $ 119,000    
Equity Appreciation Rights Plan            
Vesting period from the base date     3 years      
Redemption cash payment period     90 days      
Shares granted (in units)     57,500      
Accrued compensation 118,000   $ 118,000   $ 259,000  
2010 Plan | Equity Appreciation Rights Plan | Other Accrued Liabilities            
Equity Appreciation Rights Plan            
Accrued compensation 55,000   55,000   47,000  
2010 Plan | Equity Appreciation Rights Plan | Other Long-term Liabilities            
Equity Appreciation Rights Plan            
Accrued compensation $ 63,000   $ 63,000   $ 212,000  
2010 Plan | Equity Appreciation Rights Plan | Maximum            
Equity Appreciation Rights Plan            
Number of common shares authorized           1,000,000